Alkem Laboratories Ltd. (ALKEM): Alkem Laboratories Share Price near 52-week low as stock slips 1.83%
- September 30, 2026
- Posted by: Chaitanya Auti
- Category: News
Alkem Laboratories Share Price opened the session near its previous close and then weakened to Rs 5,140.50, leaving Alkem Laboratories Share Price Today down 1.83%. The stock is trading close to its 52-week low, and the market capitalisation stands at Rs 61,804.34 crore, which keeps Alkem Laboratories Share Price in focus for investors tracking Alkem Laboratories Share Price Today and Alkem Laboratories Stock News. The latest move confirms the price event, but the supplied data does not establish a company-specific catalyst. In that sense, Univest analysis points to a market-led move rather than a verified business trigger. For readers searching Alkem Laboratories Share News or Alkem Laboratories News Today, the key issue is simple: price action remains soft while the company’s valuation and operating ratios still matter.
Alkem Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,140.5 |
| Previous Close | Rs 5,236.4 |
| Today's Move | Rs -95.9 (-1.83%) |
| Open | Rs 5,236.25 |
| High | Rs 5,267.5 |
| Low | Rs 5,132.2 |
| Market Capitalisation | Rs 61,804.34 crore |
Alkem Laboratories Ltd. (ALKEM) traded at Rs 5,140.5 versus the previous close of Rs 5,236.4, a fall of 1.83%. The stock opened at Rs 5,236.25, reached a high of Rs 5,267.5, touched a low of Rs 5,132.2.
Alkem Laboratories Share Price Today reflects a weak session with a current price of Rs 5,140.50 versus the previous close of Rs 5,236.40. The day change was Rs -95.90, or -1.83%, after an open of Rs 5,236.25, a high of Rs 5,267.50 and a low of Rs 5,132.20. The stock finished close to the lower end of the day range, which points to selling pressure through the session. Alkem Laboratories Share Price also trades below the 50 DMA of Rs 5,266.60 and the 200 DMA of Rs 5,429.01, so the broader share price structure remains soft. For Univest readers tracking Alkem Laboratories Share Price Live, this is a clear near-52-week-low setup and a useful example of price action in a cautious Indian stock market tone. Alkem Laboratories Share Price Today will likely remain watched near support and resistance levels as market participants assess the latest stock performance.
For those asking why Alkem Laboratories Share Price is falling today, the verified data confirms the decline but does not establish a specific company event. The stock is also being discussed in the context of Stocks in News, Top Losers Today and 52 Week Low Stocks because the move is close to the yearly low zone. In price terms, the current share price is about 1.82% above the day low, so Alkem Laboratories Share Price Today remains under pressure but not at the session floor. Univest tracks such price action carefully because near-low zones often draw attention from both short-term traders and long-term investors.
Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 61,804.34 crore |
| P/E Ratio | 29.02x |
| P/B Ratio | 4.38x |
| ROE | 18.29% |
| ROCE | 21.28% |
| EPS | Rs 180.45 |
| Book Value Per Share | Rs 1,196.51 |
| Dividend Yield | 1.01% |
Alkem Laboratories Ltd. (ALKEM) fundamental metrics show P/E 29.02x, P/B 4.38x, ROE 18.29%, ROCE 21.28%. These figures provide context only and are not a buy or sell signal.
Alkem Laboratories Ltd. has a market capitalisation of Rs 61804.34 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 29.02x, P/B at 4.38x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 180.45, book value per share of Rs 1196.51, dividend yield of 1.01%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 28.2x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.02x |
| Benchmark Median P/E | 28.2x |
| Benchmark Average P/E | 42.07x |
| Benchmark P/E Range | 0x to 699.02x |
| Company P/B Ratio | 4.38x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 18.29% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 21.28% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 61,804.34 crore |
| Benchmark Median Market Cap | Rs 773.14 crore |
Alkem Laboratories Ltd. (ALKEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 29.02x, which is above the benchmark median of 28.2x, a difference of +2.91%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Alkem Laboratories Ltd. (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.7%, a difference of +56.32%. Alkem Laboratories Ltd. (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.46%, a difference of +58.1%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Biocon Ltd. | BIOCON | 61,113.53 | 124.37 | 1.81 | 1.35 | 3.26 |
| Glenmark Pharmaceuticals Ltd. | GLENMARK | 65,927.68 | 37.6 | 6.17 | 14.1 | 20.35 |
| Abbott India Ltd. | ABBOTINDIA | 56,860.69 | 35.88 | 11.19 | 34.67 | 46.72 |
| Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | 49,091.33 | 44.21 | 18.73 | 48.76 | 66.79 |
| Ipca Laboratories Ltd. | IPCALAB | 48,712.48 | 37.62 | 5.81 | 15.88 | 19.41 |
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 29.02x compared with the displayed peer median of 37.62x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.29% compares with a peer median of 15.88% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 20.35%, providing a capital-efficiency comparison. Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 61,804.34 crore. Among the 5 peers shown, 1 have a larger market capitalisation.
Why Investors Are Watching Alkem Laboratories
- Alkem Laboratories Share Price is close to its 52-week low, so the daily price action is drawing attention in the stock market today.
- The stock trades below the 50 DMA and 200 DMA, which keeps the technical analysis tone weak on longer-term momentum.
- Fundamentals remain visible, with ROE of 18.29, ROCE of 21.28, EPS of Rs 180.45 and dividend yield of 1.01%.
- The valuation is slightly above the industry median on P/E, but still well below the industry average, which keeps peer comparison relevant.
- Healthcare sector positioning matters because Alkem Laboratories Share Price is a large-cap name in Pharmaceuticals & Drugs.
About Alkem Laboratories
Alkem Laboratories Ltd. is a pharmaceutical company in the Healthcare sector and the Pharmaceuticals & Drugs industry. The business operates as a large listed healthcare company with a market capitalisation of Rs 61,804.34 crore, and its share price movement often reflects how investors view both earnings quality and sector positioning. The supplied financial data shows a substantial revenue base and steady profitability, which helps explain why Alkem Laboratories Share Price remains a stock followed for both company overview and market update purposes.
For Univest readers searching Alkem Laboratories Share Price Today or Alkem Laboratories Stock News, the important point is that the company’s scale is established, its profitability ratios are above the industry median, and its book value and EPS give the stock a measurable financial base. That makes Alkem Laboratories Share Price relevant whenever healthcare names enter the broader share market today discussion. The stock is also part of the wider conversation around market movers, price action and sector analysis in the Indian stock market.
Track Alkem Laboratories Share Price on Univest
Use Alkem Laboratories Ltd. (ALKEM) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Users can track Alkem Laboratories Share Price on Univest for live price updates, technical indicators, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest brings together Alkem Laboratories Share Price Today, Alkem Laboratories Stock Analysis and Alkem Laboratories Share News in one place so readers can compare price action with sector and peer context.
For investors monitoring Alkem Laboratories Share Price Live, Univest also helps follow the company’s latest news, market cap context and financial ratios alongside the broader stock performance. That makes it easier to keep an eye on Alkem Laboratories Share Price without losing sight of the valuation and operating picture.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Alkem Laboratories Share Price falling today?
Ans. Alkem Laboratories Share Price is down 1.83% to Rs 5,140.50. The data confirms the move near a 52-week low, but it does not establish a company-specific catalyst or event-driven trigger.
What is Alkem Laboratories Share Price today?
Ans. Alkem Laboratories Share Price today is Rs 5,140.50, compared with the previous close of Rs 5,236.40. The stock traded between Rs 5,132.20 and Rs 5,267.50 during the session. The stock moved -1.83% during the session.
Is Alkem Laboratories near its 52-week low?
Ans. Yes, Alkem Laboratories Share Price is trading close to its 52-week low. That is why it appears in stocks at 52 week low screens and in share market today discussions.
How expensive is Alkem Laboratories Share Price on valuation?
Ans. Alkem Laboratories Share Price has a P/E of 29.02 and a P/B of 4.38. Those levels are above the same-industry median, though the P/E is still below the industry average.
What are the key fundamentals behind Alkem Laboratories Share Price?
Ans. Alkem Laboratories Share Price is supported by ROE of 18.29, ROCE of 21.28, EPS of Rs 180.45, book value of Rs 1,196.51 and dividend yield of 1.01%, which adds fundamental context.
How does Alkem Laboratories compare with peers?
Ans. Alkem Laboratories Share Price is below Lupin and Aurobindo on market cap, but it compares well on profitability ratios. Its P/E is also lower than several peer valuations in the same industry.
What sector does Alkem Laboratories belong to?
Ans. Alkem Laboratories Share Price belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The same-industry benchmark covers 198 companies, which helps frame peer comparison. The stock belongs to the Healthcare sector.
What should investors monitor next for Alkem Laboratories?
Ans. Investors should monitor Alkem Laboratories Share Price near support, the 50 DMA and 200 DMA, plus valuation and sector context. Univest will continue tracking share price updates and market news.
Should investors track Alkem Laboratories Share Price on Univest?
Ans. Yes, Univest provides Alkem Laboratories Share Price Today, technical analysis, fundamental analysis and peer context in one place. That makes it useful for following stock news and share price news.